Business
Novavax COVID-19 vaccine production set back due to supply shortages – ABC News
Novavax pushes back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month due to supply shortages, dealing another blow…
Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages, dealing another blow to the federal government’s rollout plans.
Key points:
- Novavax is one of three companies the federal government struck a deal with to distribute COVID-19 vaccines in Australia
- It will need to be imported to Australia because of a lack of capable vaccine manufacturers
- The company has faced difficulties sourcing…
Continue Reading
-
Business22 hours agoWhich ASX shares are ahead of the pack in mitigating US tariffs?
-
Business18 hours agoAustralia’s highest earners are betting big on these ASX ETFs
-
General24 hours agoFrom Simone Young to Siobhan Stagg, meet the musicians making their mark on international stages
-
Business24 hours agoIf I invest $10,000 in Wesfarmers shares, how much passive income will I receive in 2026?